Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $7.13 Analyst target: $11.00 Upside: 54.28%
NeurAxis, Inc. is a neuromodulation therapy device company in the United States. The company is headquartered in Versailles, Indiana.
See the full interactive analysis & chart →Informational only — not investment advice.